Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9524 |
High Similarity |
NPD3027 |
Phase 3 |
0.9302 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.9302 |
High Similarity |
NPD1613 |
Approved |
0.9062 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8992 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8168 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8148 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.814 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8045 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.8045 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.8029 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8027 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8016 |
Intermediate Similarity |
NPD228 |
Approved |
0.8013 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.797 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7941 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7941 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7899 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7891 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7885 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7885 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7885 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7881 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7829 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7799 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7792 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7786 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7786 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7786 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7785 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7778 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7778 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7769 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7761 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7755 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7736 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7733 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7724 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7708 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7698 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7697 |
Intermediate Similarity |
NPD37 |
Approved |
0.7688 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7682 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7682 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7673 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7662 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7662 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7662 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7651 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7643 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.763 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7622 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7622 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7619 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7609 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7603 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7578 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7569 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7569 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7535 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7531 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6671 |
Approved |
0.75 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7481 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7481 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.748 |
Intermediate Similarity |
NPD968 |
Approved |
0.7468 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7464 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7451 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7439 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7423 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7422 |
Intermediate Similarity |
NPD290 |
Approved |
0.7419 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7407 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7407 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7389 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7376 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7365 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7365 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7365 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7361 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7361 |
Intermediate Similarity |
NPD5735 |
Approved |
0.736 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7357 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7351 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7351 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7347 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7347 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7324 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7319 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.7319 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.7315 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7315 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7302 |
Intermediate Similarity |
NPD291 |
Approved |
0.7297 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7285 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7285 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7279 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7279 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7279 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7278 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7267 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD2677 |
Approved |
0.726 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7259 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7248 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7241 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7241 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD5763 |
Approved |
0.723 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.723 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7208 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7208 |
Intermediate Similarity |
NPD3686 |
Approved |
0.72 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.72 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7197 |
Intermediate Similarity |
NPD5772 |
Approved |
0.7197 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7197 |
Intermediate Similarity |
NPD5773 |
Approved |
0.7197 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7192 |
Intermediate Similarity |
NPD6653 |
Approved |
0.719 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD7526 |
Approved |
0.719 |
Intermediate Similarity |
NPD52 |
Approved |
0.7188 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7172 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7153 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7123 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7103 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7103 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7092 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7091 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7086 |
Intermediate Similarity |
NPD4535 |
Phase 3 |
0.7086 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD5314 |
Approved |
0.7073 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.707 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7066 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7059 |
Intermediate Similarity |
NPD1774 |
Approved |
0.7055 |
Intermediate Similarity |
NPD3062 |
Approved |
0.7055 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD3059 |
Approved |
0.7055 |
Intermediate Similarity |
NPD3061 |
Approved |
0.7047 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7047 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7045 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7044 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7044 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7041 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7031 |
Intermediate Similarity |
NPD940 |
Approved |
0.7031 |
Intermediate Similarity |
NPD846 |
Approved |
0.7025 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7024 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7021 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7015
|
Intermediate Similarity |
NPD5535 |
Approved |